Cognitive Effect of Repetitive Transcranial Magnetic Stimulation with Cognitive Training: Long-Term Mitigation Neurodegenerative Effects of Mild Alzheimer's Disease
Juyoun Lee, E. Sohn, E. Oh, C. Song, S. Jeong, A. Lee
{"title":"Cognitive Effect of Repetitive Transcranial Magnetic Stimulation with Cognitive Training: Long-Term Mitigation Neurodegenerative Effects of Mild Alzheimer's Disease","authors":"Juyoun Lee, E. Sohn, E. Oh, C. Song, S. Jeong, A. Lee","doi":"10.6890/IJGE.202005_14(2).0009","DOIUrl":null,"url":null,"abstract":"Background: Despite several studies having reported on the cognitive effects of repetitive transcranial magnetic stimulation (rTMS) in Alzheimer's disease (AD), no studies, to date have addressed the long-term effects of rTMS with cognitive training (CT). This study was aimed to investigate the long-term effects of rTMS-CT in mild AD. Methods: Patients with mild AD (Mini-mental Status Examination [MMSE] score of 21-26), diagnosed based on the diagnostic and statistical manual of mental disorders-IV, were recruited and randomly allocated to two groups, treatment and sham, in a 2:1 ratio. We matched the acetylcholinesterase inhibitor (AChEI)-only group to the treatment group to comparing the long-term effect of rTMS-CT. Treatment group was treated for 6 weeks with high-frequency (10 Hz) rTMS-CT, whereas the other group received 6 weeks of the sham management. These groups underwent neuropsychological tests at baseline, immediately after rTMS-CT, and 6 weeks after the last rTMS-CT. Data of AChEI-only and treatment groups were analyzed changes of cognitive scores (MMSE, and clinical dementia rating-sum of boxes scales) over 3 years. Results: Among the 44 enrolled mild AD (mean age, 72.5 years; females, 36.4%), the rTMS-CT group (n = 30) showed improvement on the ADAS-Cog score for 12 weeks compared with the sham group (n = 14). The rTMS-CT group showed slower rates of neurodegeneration than those in the AChEI-only group (n = 60) during the 3 years of follow-up. Conclusions: Compared to the administration of AChEI only, the use of rTMS-CT might be a useful supplementary interventional strategy in mild AD for long-term mitigation of neurodegeneration.","PeriodicalId":50321,"journal":{"name":"International Journal of Gerontology","volume":"2 1","pages":"133-137"},"PeriodicalIF":0.3000,"publicationDate":"2020-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Gerontology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.6890/IJGE.202005_14(2).0009","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"GERIATRICS & GERONTOLOGY","Score":null,"Total":0}
引用次数: 1
Abstract
Background: Despite several studies having reported on the cognitive effects of repetitive transcranial magnetic stimulation (rTMS) in Alzheimer's disease (AD), no studies, to date have addressed the long-term effects of rTMS with cognitive training (CT). This study was aimed to investigate the long-term effects of rTMS-CT in mild AD. Methods: Patients with mild AD (Mini-mental Status Examination [MMSE] score of 21-26), diagnosed based on the diagnostic and statistical manual of mental disorders-IV, were recruited and randomly allocated to two groups, treatment and sham, in a 2:1 ratio. We matched the acetylcholinesterase inhibitor (AChEI)-only group to the treatment group to comparing the long-term effect of rTMS-CT. Treatment group was treated for 6 weeks with high-frequency (10 Hz) rTMS-CT, whereas the other group received 6 weeks of the sham management. These groups underwent neuropsychological tests at baseline, immediately after rTMS-CT, and 6 weeks after the last rTMS-CT. Data of AChEI-only and treatment groups were analyzed changes of cognitive scores (MMSE, and clinical dementia rating-sum of boxes scales) over 3 years. Results: Among the 44 enrolled mild AD (mean age, 72.5 years; females, 36.4%), the rTMS-CT group (n = 30) showed improvement on the ADAS-Cog score for 12 weeks compared with the sham group (n = 14). The rTMS-CT group showed slower rates of neurodegeneration than those in the AChEI-only group (n = 60) during the 3 years of follow-up. Conclusions: Compared to the administration of AChEI only, the use of rTMS-CT might be a useful supplementary interventional strategy in mild AD for long-term mitigation of neurodegeneration.
期刊介绍:
The Journal aims to publish original research and review papers on all fields of geriatrics and gerontology, including those dealing with critical care and emergency medicine.
The IJGE aims to explore and clarify the medical science and philosophy in all fields of geriatrics and gerontology, including those in the emergency and critical care medicine. The IJGE is determined not only to be a professional journal in gerontology, but also a leading source of information for the developing field of geriatric emergency and critical care medicine. It is a pioneer in Asia.
Topics in the IJGE cover the advancement of diagnosis and management in urgent, serious and chronic intractable diseases in later life, preventive medicine, long-term care of disability, ethical issues in the diseased elderly and biochemistry, cell biology, endocrinology, molecular biology, pharmacology, physiology and protein chemistry involving diseases associated with age. We did not limit the territory to only critical or emergency condition inasmuch as chronic diseases are frequently brought about by inappropriate management of acute problems.